Literature DB >> 22566597

Outcome and its predictors in Guillain-Barre syndrome.

Yusuf A Rajabally1, Antonino Uncini.   

Abstract

Despite the use of plasma exchanges and intravenous immunoglobulins, Guillain-Barré syndrome (GBS) still carries non-negligible morbidity and mortality. Furthermore, the psychosocial consequences of GBS may persist longer than expected. Various aetiological, clinical, electrophysiological and immunological factors may carry prognostic predictive value. The objective of this article was to perform a summary of the current knowledge-base on outcome and its determinants in adequately-treated adult-onset GBS. Relevant prospective literature was reviewed through a Medline search of English-language articles published between 1966 and March 2012. GBS causes severe persistent disability in 14% of patients at 1 year. Loss of full strength, persistent pain and need for professional change occurs in about 40%. Mortality is of about 4% within the first year. Analysis of prognostic predictors consistently demonstrates the negative impact of higher age, preceding diarrhoea, greater disability/weaker muscles at admission, short interval between symptom-onset and admission, mechanical ventilation and absent/low amplitude compound muscle action potentials. Further outcome studies will soon be underway and may in future contribute to adequately integrate all potential factors in more reliable predictive models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566597     DOI: 10.1136/jnnp-2011-301882

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

1.  Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats.

Authors:  Zhi-Ming Zhang; Rongchen Shi; Hong Chen; Zhiren Zhang
Journal:  Neurol Sci       Date:  2015-09-26       Impact factor: 3.307

2.  Association of ubiquitin carboxy-terminal hydrolase-L1 in cerebrospinal fluid with clinical severity in a cohort of patients with Guillain-Barré syndrome.

Authors:  Satoshi Nagamine; Yuuki Fujiwara; Toshio Shimizu; Akihiro Kawata; Keiji Wada; Eiji Isozaki; Tomohiro Kabuta
Journal:  Neurol Sci       Date:  2015-03-05       Impact factor: 3.307

3.  COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome.

Authors:  K L Hutchins; J H Jansen; A D Comer; R V Scheer; G S Zahn; A E Capps; L M Weaver; N A Koontz
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

4.  Guillain-Barré Syndrome and Chikungunya: Description of All Cases Diagnosed during the 2014 Outbreak in the French West Indies.

Authors:  Stephanie Balavoine; Mathilde Pircher; Bruno Hoen; Cecile Herrmann-Storck; Fatiha Najioullah; Benjamin Madeux; Aissatou Signate; Ruddy Valentino; Annie Lannuzel; Magali Saint Louis; Sylvie Cassadou; André Cabié; Kinda Schepers
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability.

Authors:  María J Sedano; Ana Canga; Carmen de Pablos; José M Polo; José Berciano
Journal:  J Neurol       Date:  2013-01-31       Impact factor: 4.849

6.  Guillain-Barre syndrome-like illness in association with electrical shock injury.

Authors:  Michelle Louise Anderson; Jonathan O'Riordan
Journal:  BMJ Case Rep       Date:  2013-10-17

7.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

Review 8.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2014-09-19

9.  Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.

Authors:  Shahar Shelly; Kamal Shouman; Pritikanta Paul; JaNean Engelstad; Kimberly K Amrami; Robert J Spinner; Divyanshu Dubey; Rocio Vazquez Do Campo; Peter J Dyck; Christopher J Klein; P James B Dyck
Journal:  Neurology       Date:  2021-03-02       Impact factor: 9.910

10.  Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome.

Authors:  Puyuan Wen; Lisha Wang; Hong Liu; Li Gong; Han Ji; Hongliang Wu; Wenzheng Chu
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.